Human African trypanosomiasis in endemic populations and travellers

被引:27
作者
Blum, J. A. [1 ]
Neumayr, A. L. [1 ]
Hatz, C. F. [1 ]
机构
[1] Swiss Trop & Publ Hlth Inst, Dept Med, CH-4002 Basel, Switzerland
关键词
GAMBIENSE SLEEPING SICKNESS; EFLORNITHINE COMBINATION THERAPY; BRUCEI-GAMBIENSE; LATE-STAGE; TB-GAMBIENSE; RISK-FACTORS; MELARSOPROL TREATMENT; CEREBROSPINAL-FLUID; CLINICAL-ASPECTS; RHODESIENSE;
D O I
10.1007/s10096-011-1403-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Human African trypanosomiasis (HAT) or sleeping sickness is caused by the protozoan parasites (West African form) and (East African form) that are transmitted by the bite of the tsetse fly, .. Whereas most patients in endemic populations are infected with , most tourists are infected with In endemic populations, HAT is characterized by chronic and intermittent fever, headache, pruritus, and lymphadenopathy in the first stage and by sleep disturbances and neuro-psychiatric disorders in the second stage. Recent descriptions of the clinical presentation of in endemic populations show a high variability in different foci. The symptomatology of travellers is markedly different from the usual textbook descriptions of African HAT patients. The onset of both infections is almost invariably an acute and febrile disease. Diagnosis and treatment are difficult and rely mostly on old methods and drugs. However, new molecular diagnostic technologies are under development. A promising new drug combination is currently evaluated in a phase 3 b study and further new drugs are under evaluation.
引用
收藏
页码:905 / 913
页数:9
相关论文
共 102 条
[51]   A traveler returning from Central Africa with fever and a skin lesion [J].
Iborra, C ;
Danis, M ;
Bricaire, F ;
Caumes, E .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) :679-680
[52]   Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine [J].
Iten, M ;
Mett, H ;
Evans, A ;
Enyaru, JCK ;
Brun, R ;
Kaminsky, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1922-1925
[53]   Characterization of Trypanosoma brucei s.l. infecting asymptomatic sleeping-sickness patients in Cote d'Ivoire:: a new genetic group? [J].
Jamonneau, V ;
Ravel, S ;
Garcia, A ;
Koffi, M ;
Truc, P ;
Laveissière, C ;
Herder, S ;
Grébaut, P ;
Cuny, G ;
Solano, P .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2004, 98 (04) :329-337
[54]   Cluster of African trypanosomiasis in travelers to Tanzanian national parks [J].
Jelinek, T ;
Bisoffi, Z ;
Bonazzi, L ;
van Thiel, P ;
Bronner, U ;
de Frey, A ;
Gundersen, SG ;
McWhinney, P ;
Ripamonti, D .
EMERGING INFECTIOUS DISEASES, 2002, 8 (06) :634-635
[55]   ELECTROCARDIOGRAPHIC CHANGES IN AFRICAN TRYPANOSOMIASIS CAUSED BY TRYPANOSOMA-BRUCEI RHODESIENSE [J].
JONES, IG ;
LOWENTHAL, MN ;
BUYST, H .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1975, 69 (04) :388-395
[56]   Novel Biomarkers for Late-Stage Human African Trypanosomiasis-The Search Goes On [J].
Kennedy, Peter G. E. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 82 (06) :981-982
[57]   Human African trypanosomiasis-neurological aspects [J].
Kennedy, PGE .
JOURNAL OF NEUROLOGY, 2006, 253 (04) :411-416
[58]   MYOCARDITIS IN TRYPANOSOMA RHODESIENSE INFECTIONS [J].
KOTEN, JW ;
DERAADT, P .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1969, 63 (04) :485-+
[59]  
KOUCHNER G, 1979, B SOC PATHOL EXOT, V72, P131
[60]   Clinical Presentation of T.b. rhodesiense Sleeping Sickness in Second Stage Patients from Tanzania and Uganda [J].
Kuepfer, Irene ;
Hhary, Emma Peter ;
Allan, Mpairwe ;
Edielu, Andrew ;
Burri, Christian ;
Blum, Johannes A. .
PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (03)